share_log

180 Life Sciences | 3: Initial statement of beneficial ownership of securities-Director Smith Ryan Lewis

SEC announcement ·  Mar 12 05:24
Summary by Futu AI
Ryan Lewis Smith, a director and 10% owner of 180 Life Sciences Corp, has filed an initial statement of beneficial ownership with the SEC, as per Form 3 requirements. The filing, dated March 7, 2024, indicates that Smith does not beneficially own any non-derivative or derivative securities of the company. The form, signed on March 11, 2024, is a standard disclosure for insiders of public companies, detailing their holdings and transactions in the company's stock. This filing is part of the regulatory compliance under Section 16(a) of the Securities Exchange Act of 1934.
Ryan Lewis Smith, a director and 10% owner of 180 Life Sciences Corp, has filed an initial statement of beneficial ownership with the SEC, as per Form 3 requirements. The filing, dated March 7, 2024, indicates that Smith does not beneficially own any non-derivative or derivative securities of the company. The form, signed on March 11, 2024, is a standard disclosure for insiders of public companies, detailing their holdings and transactions in the company's stock. This filing is part of the regulatory compliance under Section 16(a) of the Securities Exchange Act of 1934.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.